Acute breathlessness with frank hemoptysis following catheter ablation for atrial fibrillation, a cause not so obvious.
Peter Henry WaddinghamAnthony Wai-Cheong ChowPublished in: Clinical case reports (2019)
All clinicians prescribing amiodarone require knowledge of the challenging diagnosis and management of amiodarone-induced pulmonary toxicity (APT), which is potentially fatal. APT should be considered early in all patients presenting with new respiratory symptoms and concurrent amiodarone therapy. Drug cessation and corticosteroid therapy can be highly effective once recognized.
Keyphrases
- catheter ablation
- atrial fibrillation
- left atrial
- left atrial appendage
- drug induced
- healthcare
- liver failure
- oral anticoagulants
- primary care
- direct oral anticoagulants
- left ventricular
- squamous cell carcinoma
- adverse drug
- high glucose
- heart failure
- palliative care
- stem cells
- percutaneous coronary intervention
- locally advanced
- respiratory failure
- diabetic rats
- cell therapy
- bone marrow
- hepatitis b virus
- depressive symptoms
- acute coronary syndrome
- respiratory tract
- acute respiratory distress syndrome
- venous thromboembolism
- replacement therapy